6-31026289-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001395414.1(MUC22):āc.858G>Cā(p.Glu286Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,514,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001395414.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MUC22 | NM_001395414.1 | c.858G>C | p.Glu286Asp | missense_variant | 2/4 | ENST00000561890.1 | |
MUC22 | NM_001318484.1 | c.867G>C | p.Glu289Asp | missense_variant | 3/5 | ||
MUC22 | NM_001198815.1 | c.858G>C | p.Glu286Asp | missense_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MUC22 | ENST00000561890.1 | c.858G>C | p.Glu286Asp | missense_variant | 2/4 | 2 | NM_001395414.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000812 AC: 12AN: 147806Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000318 AC: 4AN: 125854Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 68892
GnomAD4 exome AF: 0.000136 AC: 186AN: 1367140Hom.: 0 Cov.: 73 AF XY: 0.000136 AC XY: 92AN XY: 674544
GnomAD4 genome AF: 0.0000812 AC: 12AN: 147806Hom.: 0 Cov.: 30 AF XY: 0.0000417 AC XY: 3AN XY: 71938
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.858G>C (p.E286D) alteration is located in exon 3 (coding exon 2) of the MUC22 gene. This alteration results from a G to C substitution at nucleotide position 858, causing the glutamic acid (E) at amino acid position 286 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at